182 related articles for article (PubMed ID: 29693002)
1. Matrix Metalloproteinase-9 Is a Predictive Factor for Systematic Hypertension and Heart Dysfunction in Patients with Obstructive Sleep Apnea Syndrome.
Wang S; Li S; Wang B; Liu J; Tang Q
Biomed Res Int; 2018; 2018():1569701. PubMed ID: 29693002
[TBL] [Abstract][Full Text] [Related]
2. Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome.
Ye J; Liu H; Li Y; Liu X; Zhu JM
Chin Med J (Engl); 2007 Sep; 120(17):1482-6. PubMed ID: 17908454
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the correlations between oxidative stress, gelatinases and their tissue inhibitors in the human subjects with obstructive sleep apnea syndrome.
Hopps E; Lo Presti R; Montana M; Canino B; Calandrino V; Caimi G
J Physiol Pharmacol; 2015 Dec; 66(6):803-10. PubMed ID: 26769829
[TBL] [Abstract][Full Text] [Related]
4. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome.
Tazaki T; Minoguchi K; Yokoe T; Samson KT; Minoguchi H; Tanaka A; Watanabe Y; Adachi M
Am J Respir Crit Care Med; 2004 Dec; 170(12):1354-9. PubMed ID: 15361365
[TBL] [Abstract][Full Text] [Related]
5. Do salivary and serum collagenases have a role in an association between obstructive sleep apnea syndrome and periodontal disease? A preliminary case-control study.
Nizam N; Basoglu OK; Tasbakan MS; Holthöfer A; Tervahartiala T; Sorsa T; Buduneli N
Arch Oral Biol; 2015 Jan; 60(1):134-43. PubMed ID: 25455127
[TBL] [Abstract][Full Text] [Related]
6. Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome.
Tamaki S; Yamauchi M; Fukuoka A; Makinodan K; Koyama N; Tomoda K; Yoshikawa M; Kimura H
Intern Med; 2009; 48(15):1255-62. PubMed ID: 19652426
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases as possible biomarkers of obstructive sleep apnea severity - A systematic review.
Franczak A; Bil-Lula I; Sawicki G; Fenton M; Ayas N; Skomro R
Sleep Med Rev; 2019 Aug; 46():9-16. PubMed ID: 31060030
[TBL] [Abstract][Full Text] [Related]
8. Heat Shock Proteins, L-Arginine, and Asymmetric Dimethylarginine Levels in Patients With Obstructive Sleep Apnea Syndrome.
İn E; Özdemir C; Kaman D; Sökücü SN
Arch Bronconeumol; 2015 Nov; 51(11):544-50. PubMed ID: 26055465
[TBL] [Abstract][Full Text] [Related]
9. Airway and alveolar nitric oxide measurements in obstructive sleep apnea syndrome.
Fortuna AM; Miralda R; Calaf N; González M; Casan P; Mayos M
Respir Med; 2011 Apr; 105(4):630-6. PubMed ID: 21232930
[TBL] [Abstract][Full Text] [Related]
10. [Cardiovascular morbidity associated with obstructive sleep apnea syndrome].
Destors M; Tamisier R; Baguet JP; Levy P; Pepin JL
Rev Mal Respir; 2014 Apr; 31(4):375-85. PubMed ID: 24750957
[TBL] [Abstract][Full Text] [Related]
11. Serum gamma-glutamyl transferase activity is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome.
Kanbay A; Kaya E; Buyukoglan H; Ozdogan N; Kaya MG; Oymak FS; Gulmez I; Demir R; Kokturk O
Respir Med; 2011 Apr; 105(4):637-42. PubMed ID: 21183328
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive biomarker profiling in patients with obstructive sleep apnea.
Maeder MT; Strobel W; Christ M; Todd J; Estis J; Wildi K; Thalmann G; Hilti J; Brutsche M; Twerenbold R; Rickli H; Mueller C
Clin Biochem; 2015 Mar; 48(4-5):340-6. PubMed ID: 25218814
[TBL] [Abstract][Full Text] [Related]
13. [Obstructive sleep apnea syndrome, endothelial dysfunction and coronary atherosclerosis].
Dursunoğlu N; Dursunoğlu D
Tuberk Toraks; 2005; 53(3):299-306. PubMed ID: 16258893
[TBL] [Abstract][Full Text] [Related]
14. Exhaled breath condensate cytokine level as a diagnostic tool for obstructive sleep apnea syndrome.
Li Y; Chongsuvivatwong V; Geater A; Liu A
Sleep Med; 2009 Jan; 10(1):95-103. PubMed ID: 18207457
[TBL] [Abstract][Full Text] [Related]
15. Lack of association of matrix metalloproteinase-9 promoter gene polymorphism in obstructive sleep apnea syndrome.
Yalcınkaya M; Erbek SS; Babakurban ST; Kupeli E; Bozbas S; Terzi YK; Sahin FI
J Craniomaxillofac Surg; 2015 Sep; 43(7):1099-103. PubMed ID: 26169999
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular aspects in obstructive sleep apnea syndrome--molecular issues, hypoxia and cytokine profiles.
Lavie L; Polotsky V
Respiration; 2009; 78(4):361-70. PubMed ID: 19786735
[TBL] [Abstract][Full Text] [Related]
17. Adipose tissue is influenced by hypoxia of obstructive sleep apnea syndrome independent of obesity.
Thorn CE; Knight B; Pastel E; McCulloch LJ; Patel B; Shore AC; Kos K
Diabetes Metab; 2017 Jun; 43(3):240-247. PubMed ID: 28131740
[TBL] [Abstract][Full Text] [Related]
18. Obstructive sleep apnea syndrome and cardiovascular diseases.
Fava C; Montagnana M; Favaloro EJ; Guidi GC; Lippi G
Semin Thromb Hemost; 2011 Apr; 37(3):280-97. PubMed ID: 21455862
[TBL] [Abstract][Full Text] [Related]
19. Reduced Peripheral Blood Mononuclear Cell ROCK1 and ROCK2 Levels in Obstructive Sleep Apnea Syndrome.
Aydin Ş; Özdemir C; Küçükali CI; Sökücü SN; Giriş M; Akcan U; Tüzün E
In Vivo; 2018; 32(2):319-325. PubMed ID: 29475915
[TBL] [Abstract][Full Text] [Related]
20. Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity.
Kent BD; Ryan S; McNicholas WT
Respir Physiol Neurobiol; 2011 Sep; 178(3):475-81. PubMed ID: 21439407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
